About us  

Since inception, the steadfast commitment to serve patient needs through therapeutic progress has aspired health care professionals at Servier to place patient and innovation at the heart of its operations. Founded in the year 1954 in Orleans (France), Servier Group’s global footprint has broadened and encompassed extensive geographic regions. Servier teams operate in various regions to supply medicines to patients in 150 countries. The Group’s strategy is to operate at local bases to offer a range of therapeutic solutions to suit the specific needs of each country. 

Servier India Private Limited is an affiliate of the renowned French MNC – the Servier Group. The Servier Group is governed by a non-profit foundation, the Foundation International de Recherche Servier (FIRS). Its governance structure is unique in the pharmaceutical industry and preserves its independence, guarantees a long-term vision, and enables it to reinvest all its profits into a single priority – therapeutic progress to serve patient needs. 

Servier India  

India had been identified early as a very important market, Servier India Private Limited has been into existence in India since 1986, Servier India employs highly competent field force professionals who always talk about their very sound scientific knowledge. The company is well-respected in the medical fraternity for its original products, strong scientific base and ethical promotion. 

The Head Office is based in Mumbai houses various departments like Product Promotion, Learning & Development, Legal Department, Sales Department, and Human Resources Department. All the departments work in oneness and sustain a harmonious relationship between colleagues, which shapes a happy and comfortable work environment where colleagues are helpful, motivating, and supportive of each other. 

Servier India is one of the few affiliates in Servier world where formulation development is done locally by the Manufacturing and Product Development Team which ensures a pipeline of new ‘Make in INDIA’ formulations for India” 

Servier India fosters an environment in which diverse individuals are all connected by their contributions towards a common goal. We thrive on cultural diversity through the sharing of knowledge and experience and encourage employee mobility within the company. 

With over 563 employees, Servier India serves 28000 healthcare professionals benefitting lakhs of patients across the country. Servier India has quickly risen to become a leading player in oral anti-diabetic and coronary artery disease segments. 

Team Servier India  

The culture at Servier India is unique and synergistic, and it focuses on building trust and confidence amongst employees, helping them develop with regards to commitment, integrity and discipline towards their job. We enable and encourage people to explore their creativity and realize their latent talents, thereby inspiring them to go beyond their normal call of duty. 

The work environment at Servier India is highly professional and yet employees bond as a family, celebrating customs and festivals in a true spirit of togetherness. Team Servier India invokes the spirit of oneness and close bonding among all Servier Indians in order to achieve superior performance year after year. Various team-building activities are held regularly in order to develop this spirit in every Servier Indian. 

Servier India Pvt. Ltd has been certified and recognized by the coveted “Great Place to Work” certification body for two consecutive years during the period spanning from April 2021 to March 2023. This achievement has indeed been a great accomplishment for the company considering that the entire world including India during the period of review was besieged with the onset of the risky pandemic. 

At Servier India Private Limited, the essential way of Employee Engagement and Work-life Blend has always been “Anthropocentric” which is invigorated by the company’s core value and belief system. This approach has been the most promising path toward optimizing the company’s performance, by getting their people put their efforts and energies together for a shared objective 

Our Vocation

We are committed to therapeutic progress to serve patient’s needs. 

Our Vision 

To put patients and innovation at the heart of all our actions 

For that –  

  • We are determined to create and provide patients with innovative therapeutic solutions that address unmet needs. 
  • We intend to strengthen our leadership in cardiovascular diseases and diabetes and to take on a leading role in the fight against cancers, immuno-inflammatory diseases and neurodegenerative diseases. 

To foster our individual and collective commitment, which is our Group’s driving force. 

With resolute – 

  • Women and men working for Servier take pride in contributing to finding cures, providing relief and saving lives. Our professionals act in an ethical way with social responsibility, respecting the environment in our actions. 
  • Focusing our energy, strengthening team spirit, promoting cross-functional collaboration and being selective in our choices are essential to our global performance. 
  • We encourage individual fulfillment and collective success by creating an environment that promotes the expression of ideas and the nurturing of talent. 

To guarantee our independence and our capacity for long-term investment. 

How ? 

  • As an internationally recognized healthcare player, our group concentrates all its resources on therapeutic progress. 
  • We aim to be economically successful in order to keep growing and to fulfill our vocation. 

To be a Group with global reach 

Integration 

  • Based on our international success, we leverage in-house skills and external partnerships to innovate and promote worldwide access to our therapeutic solutions, adapting our strategies to patient needs. 
  • We thrive on cultural diversity through the sharing of knowledge and experience and encourage employee mobility within the company. 

Through our actions, we contribute to transfer to future generations a world that can ensure access to quality health care for all. 

Our Values 

Dare to innovate 

We undertake to provide innovative therapeutic solutions. Driven by a pioneering spirit, we dare, we strive, and we accomplish together. 

Care 

We prepare for the future by embracing human and environmental dimensions. Our concern for the health and fulfillment of all is our driving force. 

Grow by sharing 

Every opportunity to work together contributes to the common good. Whoever we are, wherever we are, we grow and develop by working together, building on one another’s experiences and contributions. 

Commit to succeed 

The continuous development of the Group is vital. Whatever challenges we face, we are committed to keeping our promises. 

Message from the CEO 

Mr. Olivier Laureau is the President of the pharmaceutical group Servier and the Servier International Foundation for Research since 2014. 

We are a global pharmaceutical Group governed by a non-profit Foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to transmit to future generations a world that can ensure access to quality health care for all. 

Relying on a solid geographical presence and revenue of €4.7 billion in 2021 achieved in 150 countries, we employ 21,800 people worldwide. We are an independent group that invests over 20% of its brand-name revenue in Research and Development every year. 

A leader in cardiology, our ambition is to become a renowned and innovative player in oncology. Our growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. 

Our R&D centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in our 16 production centres around the world. 98% of Servier brand-name medicine’s active ingredients are synthesized in its own plant in Bolbec-Baclair in France. 

To accelerate therapeutic innovation for the benefit of patients, we are committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. We also integrate the patient’s voice at the heart of our activities, from research to support beyond the pill. 

All Group employees are driven by shared Values and guided by a common Vision. Together we share the passion of entrepreneurship and we are committed to therapeutic progress to serve patient needs.”